Physician profile
Ryan Carr
NPI 1366820789
$417.15
in general payments reported to CMS, 2019-2025
6 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $46.86 · 2023: $97.59 · 2024: $134 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $140.09 | 2022-2024 | Reblozyl |
| Tempus Ai, INC | $81.68 | 2025 | Xt Cdx |
| Jazz Pharmaceuticals INC. | $80.68 | 2023-2024 | |
| Glaxosmithkline, LLC. | $65.54 | 2023-2025 | Ojjaara |
| Janssen Biotech, INC. | $32.52 | 2025 | Darzalex, Tecvayli, Talvey |
| Novartis Pharmaceuticals Corporation | $16.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.